These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11127875)

  • 1. In situ analysis of tissue factor-dependent thrombin generation in human atherosclerotic vessels.
    Westmuckett AD; Lupu C; Goulding DA; Das S; Kakkar VV; Lupu F
    Thromb Haemost; 2000 Nov; 84(5):904-11. PubMed ID: 11127875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early atherosclerosis exhibits an enhanced procoagulant state.
    Borissoff JI; Heeneman S; Kilinç E; Kassák P; Van Oerle R; Winckers K; Govers-Riemslag JW; Hamulyák K; Hackeng TM; Daemen MJ; ten Cate H; Spronk HM
    Circulation; 2010 Aug; 122(8):821-30. PubMed ID: 20697022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X.
    Thiruvikraman SV; Guha A; Roboz J; Taubman MB; Nemerson Y; Fallon JT
    Lab Invest; 1996 Oct; 75(4):451-61. PubMed ID: 8874378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of tissue factor-factor VIIa-factor Xa complex prevents apoptosis in human breast cancer cells.
    Jiang X; Guo YL; Bromberg ME
    Thromb Haemost; 2006 Aug; 96(2):196-201. PubMed ID: 16894464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. III. Instantaneous inhibition by compound 48/80 of tissue factor-initiated extrinsic coagulation is mediated by the downregulation of factor VII activation.
    Chu AJ; Wang ZG; Fox MJ
    Arch Biochem Biophys; 2000 May; 377(2):357-65. PubMed ID: 10845714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
    Norledge BV; Petrovan RJ; Ruf W; Olson AJ
    Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein.
    Bogdanov VY; Balasubramanian V; Hathcock J; Vele O; Lieb M; Nemerson Y
    Nat Med; 2003 Apr; 9(4):458-62. PubMed ID: 12652293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma tissue factor plus activated peripheral mononuclear cells activate factors VII and X in cardiac surgical wounds.
    Hattori T; Khan MM; Colman RW; Edmunds LH
    J Am Coll Cardiol; 2005 Aug; 46(4):707-13. PubMed ID: 16098440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a homozygous Gly11Val mutation in the Gla domain of coagulation factor X.
    Chafa O; Tagzirt M; Tapon-Bretaudière J; Reghis A; Fischer AM; LeBonniec BF
    Thromb Res; 2009 May; 124(1):144-8. PubMed ID: 19135706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute release of tissue factor pathway inhibitor after in vivo thrombin generation in baboons.
    Lupu C; Kruithof EK; Kakkar VV; Lupu F
    Thromb Haemost; 1999 Dec; 82(6):1652-8. PubMed ID: 10613651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma.
    Duchemin J; Pan-Petesch B; Arnaud B; Blouch MT; Abgrall JF
    Thromb Haemost; 2008 Apr; 99(4):767-73. PubMed ID: 18392335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor.
    van 't Veer C; Hackeng TM; Delahaye C; Sixma JJ; Bouma BN
    Blood; 1994 Aug; 84(4):1132-42. PubMed ID: 8049429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels.
    Crawley J; Lupu F; Westmuckett AD; Severs NJ; Kakkar VV; Lupu C
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1362-73. PubMed ID: 10807755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extrahepatic synthesis of factor VII in human atherosclerotic vessels.
    Wilcox JN; Noguchi S; Casanova J
    Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):136-41. PubMed ID: 12524237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of tissue factor in cardiovascular disease.
    Jude B; Zawadzki C; Susen S; Corseaux D
    Arch Mal Coeur Vaiss; 2005 Jun; 98(6):667-71. PubMed ID: 16007822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of storage-induced platelet microparticles on the initiation and propagation phase of blood coagulation.
    Keuren JF; Magdeleyns EJ; Govers-Riemslag JW; Lindhout T; Curvers J
    Br J Haematol; 2006 Aug; 134(3):307-13. PubMed ID: 16848773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation factors VII and X induce Ca2+ oscillations in Madin-Darby canine kidney cells only when proteolytically active.
    Camerer E; Rottingen JA; Iversen JG; Prydz H
    J Biol Chem; 1996 Nov; 271(46):29034-42. PubMed ID: 8910556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of tissue factor pathway inhibitor and anti-beta-2-glycoprotein-I IgG on thrombin generation.
    Lean SY; Ellery P; Ivey L; Thom J; Oostryck R; Leahy M; Baker R; Adams M
    Haematologica; 2006 Oct; 91(10):1360-6. PubMed ID: 17018385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phospholipid regulates the activation of factor X by tissue factor/factor VIIa (TF/VIIa) via substrate and product interactions.
    Hathcock JJ; Rusinova E; Gentry RD; Andree H; Nemerson Y
    Biochemistry; 2005 Jun; 44(22):8187-97. PubMed ID: 15924438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor.
    Hackeng TM; Seré KM; Tans G; Rosing J
    Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3106-11. PubMed ID: 16488980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.